By the Numbers: New Biologic License Application Filings and Drug Approvals, 2007-2016.
The FDA approved 22 novel drugs in 2016, down from 45 in 2015. Four of the new therapies are for cancer treatment, and two are for cancer diagnosis.
D001688:Biological Products; D017277:Drug Approval / Q000458:organization & administration*; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D001688:Biological Products